The present disclosure relates to novel compounds having vitamin D receptor agonist and histone deacetylase inhibitory efficacy as well as methods for reducing or inhibiting the proliferation of cancer cells or for treating cancer.
本公开涉及具有
维生素D受体激动剂和组蛋白
去乙酰化酶抑制剂功效的新化合物,以及用于减少或抑制癌细胞增殖或治疗癌症的方法。